Viridian Therapeutics, Inc.
VRDN· Nasdaq
VRDNViridian Therapeutics, Inc.
Filed May 15, 2015 · 10-Q · 45 days after period end · 0001171843-15-002907
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $1.32M | $1.48M |
| Net Income | -$2.63M | -$706.00K |
| EPS Diluted | -$0.45 | -$3.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Viridian Therapeutics, Inc. · CIK 1590750 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end
